Literature DB >> 5365345

Hepatic fluorescence in porphyria cutanea tarda studied in fine needle aspiration biopsy smears.

O Lundvall, L Enerbäck.   

Abstract

Fine needle aspiration biopsy smears from 19 patients with porphyria cutanea tarda were studied by fluorescence microscopy. Fluorescence was arbitrarily graded from 0 to 4. All patients-those with clinically manifest as well as those with latent disease-showed bright red fluorescence of porphyrin type in the liver cells, though in latent cases the fluorescence commonly was of a low grade. In patients with manifest disease fluorescence of grade 3 or 4 was present. In patients with fluorescence of grades 1 or 2 the uroporphyrin excretion in urine was normal or slightly increased. At higher grades all levels of porphyrin excretion were encountered. Of 22 control subjects, only one showed hepatic fluorescence of a porphyrin character. The control patient with a positive finding was found to have definitely increased urinary uroporphyrin excretion and probably has latent porphyria cutanea tarda. The procedure described should be useful as a screening test for hepatic cutaneous porphyria.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5365345      PMCID: PMC474365          DOI: 10.1136/jcp.22.6.704

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  THE HISTOPATHOLOGY OF THE LIVER IN ACQUIRED (SYMPTOMATIC) PORPHYRIA.

Authors:  C J UYS; L EALES
Journal:  S Afr J Lab Clin Med       Date:  1963-12

2.  An investigation of porphyria cutanea tarda.

Authors:  G HOLTI; C RIMINGTON; B C TATE; G THOMAS
Journal:  Q J Med       Date:  1958-01

3.  The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine.

Authors:  D MAUZERALL; S GRANICK
Journal:  J Biol Chem       Date:  1956-03       Impact factor: 5.157

4.  Porphyrin content of bone marrow and liver in the various forms of porphyria.

Authors:  R SCHMID; S SCHWARTZ; C J WATSON
Journal:  AMA Arch Intern Med       Date:  1954-02

5.  Porphyria in the African: a study of 100 cases.

Authors:  N M LAMONT; M HATHORN; S M JOUBERT
Journal:  Q J Med       Date:  1961-10

6.  Routine analysis of porphyrines in urine.

Authors:  R ASKEVOLD
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

7.  Porphyrin chromogens or precursors in urine, blood, bile, and feces.

Authors:  C J WATSON; R PIMENTA de MELLO; S SCHWARTZ; V E HAWKINSON; I BOSSENMAIER
Journal:  J Lab Clin Med       Date:  1951-06

8.  The spectrophotometric determination of uroporphyrin.

Authors:  C RIMINGTON; S L SVEINSSON
Journal:  Scand J Clin Lab Invest       Date:  1950       Impact factor: 1.713

9.  Studies of the clinical and metabolic effects of phlebotomy treatment in porphyria cutanea tarda.

Authors:  O Lundvall; A Weinfeld
Journal:  Acta Med Scand       Date:  1968-09

10.  Treatment of symptomatic porphyria by venesection.

Authors:  R Hickman; S J Saunders; L Eales
Journal:  S Afr Med J       Date:  1967-05-06
View more
  6 in total

1.  [Laboratory tests and therapeutic strategies for the porphyrias].

Authors:  P Poblete-Gutiérrez; T Wiederholt; H F Merk; J Frank
Journal:  Hautarzt       Date:  2006-06       Impact factor: 0.751

Review 2.  The porphyrias: a review.

Authors:  G H Elder; C H Gray; D C Nicholson
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

3.  Discoid lupus erythematosus, fatty infiltration of liver (alcoholic) and porphyria.

Authors:  A Macdonald
Journal:  Proc R Soc Med       Date:  1972-08

4.  Properties and distribution of liver fluorescence in porphyria cutenua tarda (PCT).

Authors:  L Enerbäck; O Lundvall
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1970

5.  Chronic hepatic porphyria in chronic aggressive hepatitis.

Authors:  M Doss; D Look; H Henning
Journal:  Klin Wochenschr       Date:  1971-01

6.  "Triple Observation Method (TOM)" to discriminate optically autofluorescence from porphyrins versus that from copper-metallothioneins.

Authors:  Kenji Nakayama; Yoshinobu Katoh; Mamoru Tamura
Journal:  J Fluoresc       Date:  2010-11-25       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.